MetLife Investment Management, LLC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 92 filers reported holding EIDOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 3.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$574,215
+103.8%
4,364
-21.7%
0.01%
+100.0%
Q3 2020$281,755
+6.0%
5,5760.0%0.00%0.0%
Q2 2020$265,808
-2.7%
5,5760.0%0.00%
-25.0%
Q1 2020$273,168
-14.6%
5,5760.0%0.00%
+33.3%
Q4 2019$320,007
+59.5%
5,5760.0%0.00%
+50.0%
Q3 2019$200,569
-23.7%
5,576
-34.0%
0.00%
-33.3%
Q2 2019$262,719
+32.5%
8,4530.0%0.00%
+50.0%
Q1 2019$198,2238,4530.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$147,847,00025.39%
Affinity Asset Advisors, LLC 225,000$29,606,00015.69%
Chicago Capital Management, LLC 79,922$10,516,0008.38%
Opaleye Management Inc. 315,550$41,520,0005.42%
Board of Trustees of The Leland Stanford Junior University 265,670$34,957,0002.46%
Kellner Capital, LLC 26,357$3,468,0001.83%
SPRING CREEK CAPITAL LLC 140,000$18,421,0001.35%
AQR Arbitrage LLC 274,853$36,165,0001.27%
Magnetar Financial LLC 599,330$78,860,0001.11%
ALPINE ASSOCIATES MANAGEMENT INC. 184,221$24,240,0000.99%
View complete list of EIDOS THERAPEUTICS INC shareholders